Recent News

• 04.16.2025 - Vaxart to Present at World Vaccine Congress Washington 2025 on April 23
• 04.16.2025 - Vaxart to Present at World Vaccine Congress Washington 2025 on April 23
• 04.16.2025 - Vaxart to Present at World Vaccine Congress Washington 2025 on April 23
• 03.27.2025 - Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 03.27.2025 - Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 03.27.2025 - Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Recent Filings

• 04.10.2025 - DEF 14A Other definitive proxy statements
• 04.10.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.10.2025 - ARS Annual Report to Security Holders
• 04.08.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 04.01.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.01.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.31.2025 - PRE 14A Other preliminary proxy statements
• 03.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.26.2025 - 4 Statement of changes in beneficial ownership of securities